This post is from a suggested group
Duchenne Muscular Dystrophy Treatment: Advancements and Hope
Duchenne Muscular Dystrophy (DMD) is a rare and severe genetic disorder characterized by progressive muscle degeneration and weakness. Affecting approximately 1 in every 3,500 to 5,000 male births worldwide, DMD is caused by mutations in the dystrophin gene, which plays a crucial role in maintaining muscle integrity. Although DMD currently has no definitive cure, a range of treatment options and supportive therapies aim to slow disease progression, improve quality of life, and extend life expectancy.
Understanding the Importance of Early Intervention
Early diagnosis of DMD is critical to effective disease management. Children with DMD often show symptoms such as delayed motor milestones, frequent falls, difficulty climbing stairs, and enlarged calves due to muscle fibrosis. Once diagnosed, a multidisciplinary approach involving neurologists, physiotherapists, cardiologists, and pulmonologists is recommended to address the wide-ranging effects of the disorder. Early intervention can significantly improve mobility, delay complications,…
